BEMREMERAN
UNII J87X96APT2

Substance Identification & Data

This profile provides standardized clinical and technical data for Bemremeran, uniquely identified by the FDA Unique Ingredient Identifier (UNII) J87X96APT2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2931519-21-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
J87X96APT2
CAS Registry Number
2931519-21-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BEMREMERAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C206881
National Cancer Institute reference terminology for clinical and research data.
INN ID
13295
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bemremeran. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEMREMERAN

Common Names & Synonyms

BEMREMERAN [INN]
MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING THE CODON-OPTIMIZED RECEPTOR BINDING DOMAIN (RBD) OF THE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) GLYCOPROTEIN (OMICRON VARIANT XBB.1.5; BASED UPON GISAID EPI_ISL_16433058), WITH A CYSTEINE TO SERINE SUBSTITUTION AT RESIDUE 233 (CORRESPONDING TO CYS534 IN THE FULL-LENGTH SPIKE GLYCOPROTEIN), EXPRESSED AS A FUSION PROTEIN WITH THE S GLYCOPROTEIN SIGNAL PEPTIDE DERIVED FROM SARS-COV-2 WUHAN-HU 1 STRAIN (GENBANK: MN908947.3), FLANKED BY 5' AND 3' UNTRANSLATED REGIONS (UTRS) DERIVED FROM THE HUMAN .BETA.-GLOBIN GENE AND A 3' POLYADENYLATION (POLYA) TAIL; CONTAINS 5-METHYLURIDINE INSTEAD OF URIDINE (ALL-U>5-ME-U) AND 5-METHYLCYTIDINE INSTEAD OF CYTIDINE (ALL-C>5-ME-C)
RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-AM)-CAPPED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 XBB.1.5 VARIANT (1-13)-(315-537)-SPIKE GLYCOPROTEIN PRECURSOR (534-SERINE) PLUS HUMAN .BETA.-GLOBIN 5'- AND 3'-UNTRANSLATED FLANKING REGION-CONTAINING POLY(A)-TAILED MESSENGER DS05243268), INNER SALT

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus